21, 2017 /PRNewswire/ -- In December 2017, OWC Pharmaceutical Research Corp (OTCQB: OWCP) received a new permit from the Israel Medical Cannabis Agency [MCA] to proceed with the safety study of their oral disintegrating tablet. The study protocol will be submitted to the Institutional Review ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment